USE OF ANTI-IL-12 ANTIBODIES IN TRANSPLANTATION REJECTION
摘要
<p>Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.</p>
